MADHAVAN BALACHANDRAN

Profile

First Name

: MADHAVAN

Middle Name

:

Last Name

: BALACHANDRAN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
AMGEN INC
DAVID BALTIMORE, DAVID W BEIER, FRANK J BIONDI, JR., FRANK J. BIONDI, JR., FABRIZIO BONANNI, ROBERT A BRADWAY, ROBERT A. BRADWAY, VANCE COFFMAN, VANCE D COFFMAN, VANCE D. COFFMAN, FRANCOIS DE CARBONNEL, THOMAS DITTRICH, THOMAS J.W. DITTRICH, ROBERT A. ECKERT, GREG C. GARLAND, SEAN E. HARPER, REBECCA HENDERSON, REBECCA M. HENDERSON, FRANK C HERRINGER, FRANK C. HERRINGER, ANTHONY C. HOOPER, TYLER JACKS, MICHAEL A. KELLY, BRIAN M MCNAMEE, BRIAN M. MCNAMEE, DAVID W. MELINE, GILBERT S OMENN, GILBERT S. OMENN, CYNTHIA PATTON, CYNTHIA M. PATTON, JONATHAN PEACOCK, JONATHAN M PEACOCK, JUDITH C PELHAM, JUDITH C. PELHAM, DAVID PIACQUAD, J PAUL REASON, J. PAUL REASON, ANNA S RICHO, LEONARD D SCHAEFFER, LEONARD D. SCHAEFFER, DAVID J SCOTT, DAVID J. SCOTT, KEVIN W SHARER, RONALD D SUGAR, RONALD D. SUGAR, SCOTT A. TROSS, STUART A. TROSS, R. SANDERS WILLIAMS
DIRECTOR
CATALENT, INC.
J. MARTIN CARROLL, JOHN R. CHIMINSKI, ROLF A. CLASSON, ROSEMARY A. CRANE, STEVEN L. FASMAN, JOHN J. GREISCH, WETTENY JOSEPH, CHRISTA KREUZBURG, GREGORY T. LUCIER, ALESSANDRO MASELLI, DONALD E. MOREL JR., JACK L. STAHL, PETER ZIPPELIUS
EXECUTIVE OFFICER, DIRECTOR
ADRX, INC.
MARCIN APOSTOL, JOHN FRANK, REZA HALSE, DOUG LANE, JAMES TREANOR, DAVID WILCOX, GARY WILCOX
DIRECTOR
A2 BIOTHERAPEUTICS, INC.
SRINI AKKARAJU, SCOTT FORAKER, MICHAEL GALLO, WILLIAM GO, DAVID GOEDDEL, ALEXANDER KAMB, C. ALEXANDER KAMB, SUSAN L. KELLEY, HELEN S. KIM, THOMAS LEUNG, JAKOB LOVEN, DAVID LUCAS
EXECUTIVE OFFICER
NUTCRACKER THERAPEUTICS, INC.
SAMUEL DEUTSCH, BENJAMIN ELDRIDGE, IGOR KHANDROS, ROBERT NELSEN, JAMES ZHU
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2022-11-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2021-09-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
2020-12-07
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-12-01 
2020-10-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-30 
2020-10-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-30 
2020-10-13
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-09-02 
2020-10-13
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-11-20 
2020-10-13
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2016-04-07 
2020-10-02
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-09-12 
2019-05-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
OVER $100,000,000 
Equity 
2019-05-17 
2015-01-23
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28 
2014-01-29
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28 
2013-02-04
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2011-09-28